Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Cash from Financing Activities (2016 - 2025)

CV Sciences' Cash from Financing Activities history spans 14 years, with the latest figure at -$234000.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 139.66% year-over-year to -$234000.0; the TTM value through Sep 2025 reached -$256000.0, down 182.32%, while the annual FY2024 figure was $32000.0, 102.3% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was -$234000.0 at CV Sciences, down from -$167000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $2.9 million in Q1 2021 and bottomed at -$872000.0 in Q1 2023.
  • The 5-year median for Cash from Financing Activities is -$56000.0 (2023), against an average of $221631.6.
  • The largest annual shift saw Cash from Financing Activities surged 8800.0% in 2021 before it tumbled 498.21% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $879000.0 in 2021, then crashed by 183.96% to -$738000.0 in 2022, then skyrocketed by 92.41% to -$56000.0 in 2023, then crashed by 498.21% to -$335000.0 in 2024, then surged by 30.15% to -$234000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Cash from Financing Activities are -$234000.0 (Q3 2025), -$167000.0 (Q2 2025), and $480000.0 (Q1 2025).